Who we Are
Industry veteran operators.
Traditional finance professionals.
Digital entrepreneurs.
Advisors
Advisor
Eyal Orion
Bio
Eyal is a serial entrepreneur in the healthcare sector specializing in MedTech, AI & imaging solutions.
Currently the CEO of VGS & board member of multiple companies in the sector, Eyal has dedicated his life work to improving patients’ quality of life.
Advisor
Lynn-Allison Durham
Bio
Lynn is the founder & CEO of Stalicla, a precision medicine company developing the next generation of drugs for patients with Neurodevelopment Disorders, currently focused on three compounds targeted at Autism Spectrum Disorders.
Lynn has a superior vision and understanding of the future and the viability of potential innovations in her field.
Advisor
Dorian Averbuch
Bio
Dorian is the founder of Body Vision Medical and the pioneer in the field of image-guided procedures and intra-body navigation. A medical device business leader and entrepreneur with over 20 patents that essentially found their way into commercial products, he is well known for his technical excellence and ability to propose simple, durable solutions to complex problems.
Advisor
Amit Gilon
Bio
Amit is an early-stage investor in Israel. He has over 20 years of experience in the tech industry as both an entrepreneur and investor.
Served as a BOD active member at 6 companies, and as a mentor and advisor to several others, Amit is one of the most active investors in the Israeli entrepreneurship ecosystem.
Advisor
Patrick Yee
Bio
Patrick is the co-founder of several consumer-focused startups both in the content creation and DTC sales sectors.
He’s held multiple marketing executive positions and is currently CMO at Callisto Media.
Our Values
01. Dedicated diligence at every stage
02. Insight-Driven Decisions
03. Solutions targeting tangible problems
04. Pursuing Autonomy
05.Non-zero Sum Game
From its origins, Akilia Partners invested opportunity by opportunity without the benefit of diversification that a fund may acquire from portfolio construction. The approach has required us to maximize the opportunity/risk ratio in all our decisions.
To do so, dedicated diligence has been core to our opportunity selection, both in market sizing & dynamics, problem-solving rationale, risks analysis, and key company capabilities.
We have always been driven by conviction and not trends. “Why?” is the most important question to understand. We use multiple data sources and industry advisors to reach the conclusions that drive our decisions. While data is essential to recognize patterns, industry & sector-specific knowledge is key to finding outliers and anticipating potential outcomes.
We look for companies innovating to fix obsolete processes or standards in different industries. We consider a deep understanding of today’s situation as a requirement to identify the pain points to build a pragmatic and executable plan.
We like supporting the teams building the technologies that will enable the autonomy of the individual by self-sustaining their lives through improved health, financial inclusion, energy availability & access to quality information. We believe technology is an enabler for efficiency across all industries. Efficiency increases the availability of resources, being the only sustainable path to achieving global welfare.
We believe in positive-sum games and maintain a flexible approach to funding rounds, becoming our entrepreneurs and co-investors’ long-term partners. Building a supportive & resourceful cap table is key to a company’s success, and we will always try to help entrepreneurs without pushing for minimum ownership quotas.
In Venture Capital, long-term success can only be achieved by building a collaborative environment.
5, 28004 Madrid, Spain